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Background: Many healthcare interventions are of complex nature, consisting of several interacting components.
Complex interventions are often described inadequately. A reporting guideline for complex interventions was
published in 2012 (Criteria for Reporting the Development and Evaluation of Complex Interventions in healthcare,
CReDECI) and was recently checked for its practicability. The reporting guideline was developed following the
recommendations of the EQUATOR network but excluding a formal consensus process. Therefore, a consensus
process was initiated, to revise the reporting guideline.
Methods: We used a three-phase consensus process consisting of (1) a web-based feedback survey on the published
reporting guideline, (2) a face-to-face consensus conference, and (3) a final online review and feedback round to create
the revised CReDECI. The consensus process was organized and conducted via the REFLECTION network.
Results: A total of 45 attendees from 16 European countries took part in the face-to-face consensus conference. The
revised reporting guideline (CReDECI 2) comprises 13 items on three stages: development, feasibility and piloting, and
evaluation of a complex intervention. Each item is illustrated by an explanation and an example. In contrast with most
of the available reporting guidelines, CReDECI 2 does not focus on a specific study design, to reflect the use of different
qualitative and quantitative designs and methods in the development and evaluation of complex interventions.
Conclusions: CReDECI 2 is a formally consented reporting guideline aiming to improve the reporting quality of the
development and evaluation stages of complex interventions in healthcare. Since the guideline does not focus on a
specific study design, design-specific reporting guidelines may additionally be used.
Keywords: complex interventions, consensus process, reporting guideline, research designBackground
The quality of reports of empirical studies has become an
important issue in the last two decades. In 1996, the first
CONSORT statement was published to improve the report-
ing quality of randomized controlled trials (RCTs) [1]. In
the following years, reporting guidelines for various study
designs or specific types of study design, such as cluster
RCTs or pragmatic trials, have been published. In 2006, the
EQUATOR network was established, which aimed at* Correspondence: Ralph.Moehler@uni-wh.de
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search literature by promoting transparent and accurate
reporting and wider use of robust reporting guidelines [2].
At the time of writing, more than 200 reporting guidelines
are listed in the EQUATOR database [3].
Another topic that has been discussed intensively in
recent years reflects the challenges of developing and
evaluating complex healthcare interventions. Complex
interventions consist of several components, which can
act either independently or interdependently [4]. Charac-
teristics that make interventions complex are different
professions or different organizational levels targeted by the
intervention (context of the intervention) and/or a need to
tailor the intervention for specific settings (flexibility of the
intervention) [4]. Most nonpharmacological, behavioralrticle distributed under the terms of the Creative Commons Attribution License
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plex interventions [4,5]. In 2000, the British Medical
Research Council (MRC) developed a framework for the
development and evaluation of complex interventions of-
fering methodological guidance [6]. An intensive discussion
on methodological aspects of this framework led to an up-
dated version in 2008 [4]. The MRC framework offered
methodological recommendations for the development,
feasibility and piloting, evaluation, and long-term imple-
mentation of complex interventions. Additionally, the
framework recommended comprehensive reporting of all
stages within the research process, adhering to the relevant
reporting guidelines [4]. A specific reporting guideline,
however, was lacking until 2012. Therefore, we developed
the Criteria for Reporting the Development and Evaluation
of Complex Interventions in healthcare (CReDECI) [7]. In
contrast with most reporting guidelines, CReDECI does not
offer criteria for a specific study design, but on the process
of development, piloting, and evaluation of complex in-
terventions. Several reporting guidelines or criteria sets
are available, which cover relevant aspects for compre-
hensive reporting of complex interventions (Table 1).
However, the majority of these guidelines are CON-
SORT extensions and have been developed solely to be
used for the publication of RCTs. For complex interven-
tions, comprehensive reporting of all stages of the re-
search process is required (as recommended by the
MRC framework [4]). For example, the development of
complex interventions is often reported in an extra pub-
lication or in the study protocol of the evaluation study,
where CONSORT [8] is not applicable.Table 1 Available reporting guidelines covering aspects
of complex interventions
Title Content
CONSORT extensions for cluster
randomized controlled trials [9],
nonpharmacological interventions [10],
pragmatic trials [11], social and
psychological intervention trials
(under development) [12]
Comprise some aspects also




focused on clinical trials
(randomized controlled trials)
Workgroup for Intervention
Development and Evaluation Research
recommendations [13]




Template for Intervention Description
and Replication [14]
Focuses on a comprehensive
description of interventions to
improve replicability.
Developed as an extension of
the CONSORT 2010 statement
(item 5) [8] and the SPIRIT 2013
statement (item 11) [15]
Grant et al. [16] Set of criteria for reporting
process evaluation in (cluster)
randomized controlled trials of
complex interventionsThe first version of the CReDECI guideline comprised
16 items, covering the development, feasibility and pilot-
ing, and evaluation stages of complex interventions. CRe-
DECI proved to be a feasible instrument [17]. The
guideline was created adhering to the recommendations
of the EQUATOR network, with the exception of a formal
consensus process [18]. Therefore, we aimed to revise the
CReDECI list based on a formal consensus conference.
Methods
Design and participants
The original CReDECI guideline was revised in three
steps: (1) feedback on the first CReDECI guideline was
collected via online questionnaires, (2) a face-to-face con-
sensus conference was held to develop a draft revised
guideline, and (3) the revised guideline was sent to all con-
sensus conference attendees to reach a final consensus.
Participants for the consensus process were recruited via
the REFLECTION network [19]. REFLECTION is a
European research network, funded by research coun-
cils and academies from eight European countries under
the umbrella of the European Science Foundation. RE-
FLECTION aims to promote high quality research on
complex nursing interventions and to share knowledge
and expertise [19].
Procedure
To collect feedback on aspects relevant for revising the
reporting guideline, an online questionnaire was developed
and piloted. Participants were invited to comment on all
items of the original CReDECI guideline (including the ex-
planations and examples). In addition, we asked for general
feedback on the guideline, as well as comments on aspects
omitted in the included stages (development, piloting, and
evaluation of a complex intervention). Within the RE-
FLECTION network, a specific group of 38 researchers
was formed for the consensus process. The questionnaire
was distributed via this group and was available online for
six months (April 2013 to end of September 2013). All
group members were invited to complete the questionnaire
and two reminders were sent. Based on the online feed-
back, a draft revision of the guideline was prepared for dis-
cussion at the face-to-face consensus conference. This
conference was held at the REFLECTION masterclass on
methods of complex interventions in October 2013 in
Nitra, Slovakia. The REFLECTION masterclass offers sem-
inars and workshops on specific topics of complex inter-
ventions research. Participation is open to European
healthcare researchers working in the field of complex in-
terventions. In addition to members of the REFLECTION
network consensus group, all the participants of the
masterclass were invited to join the consensus conference.
A total of 45 participants took part in the consensus
conference. The attendees were researchers in the field
Table 2 CReDECI 2 checklist
Item Reported on page
or in publication
First stage: Development
1 Description of the intervention’s
underlying theoretical basis
2 Description of all intervention components,
including the reasons for their selection
as well as their aims / essential functions
3 Illustration of any intended interactions
between different components
4 Description and consideration of the
context’s characteristics in intervention
modelling
Second stage: Feasibility and piloting
5 Description of the pilot test and its impact
on the definite intervention
Third stage: Evaluation
6 Description of the control condition
(comparator) and reasons for the selection
7 Description of the strategy for delivering
the intervention within the study context
8 Description of all materials or tools used
delivery the intervention
9 Description of fidelity of the delivery
process compared the study protocol
10 Description of a process evaluation and its
underlying theoretical basis
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psychology from 16 European countries. Of the 45
attendees, 19 were professors, another 16 had a PhD,
and nine had a master’s degree. Six attendees were also
editors or members of editorial boards of nursing or
healthcare journals. All attendees had experience in the
development and evaluation of complex healthcare in-
terventions and several had conducted or coordinated
evaluation studies (partly as consortium members of
multinational projects funded by the European Union).
The conference started with a brief presentation of the
original CReDECI list and an introduction about the aim
and methods of the consensus conference. Following
this, attendees were divided into three groups of equal
size to discuss a set of items in detail. Each group was
provided with all the comments from the online round
and the first draft revision of the group’s items. In each
group, one author of the original CReDECI list (RM, SK,
GM) moderated the discussions and collected the feed-
back. The group meetings lasted 90 minutes. Afterwards,
the participants met again to discuss the changes pro-
posed by the three groups and a final draft of the items
with their explanations and examples was developed.
Based on the comments and changes from the consen-
sus conference, a final draft was created by the authors
and sent to all participants of both the consensus con-
ference and the REFLECTION group (59 participants).
After a further round of additional comments, the final
revised guideline was approved.
Participants informally consented to take part in this
study. No formal written informed consent was collected
as all attendees volunteered to join the REFLECTION
project as well as the workshop. All attendees were in-
formed that they would be acknowledged in this publica-
tion (see acknowledgement).
The original CReDECI tool had been developed
based on a systematic literature review of the meth-
odological literature about the development and
evaluation of complex interventions in healthcare [7].
Although mostly researchers from the nursing field
were involved in the development of the tools, both
CReDECI and CReDECI 2 have not been developed
specifically for studies in nursing or any other discip-
line, but for generic use in all healthcare interven-
tions (equally to the MRC framework [4]).11 Description of internal facilitators and
barriers potentially influencing the delivery
of the intervention as revealed by the process
evaluation
12 Description of external conditions or factors
occurring during the study which might have
influenced the delivery of the intervention or
mode of action ( how it works)
13 Description of costs or required resources for
the delivery of the interventionResults
The CReDECI 2 list comprises 13 items for the stages
development, piloting, and evaluation of a complex
intervention (compared with 16 items in the original
list). Four items were merged and one item was split.
For each item, an explanation and an example is pre-
sented (an overview of the original and the revisedcriteria is presented in Additional file 1). In contrast
with the first CReDECI guideline, the revised list com-
prises examples from real studies.
The revised criteria list (CReDECI 2)
In the following, all items of CReDECI 2 are pre-
sented. A reference is given for each example; how-
ever, references within examples are not displayed,
but indicated by [Ref.]. A checklist with all items but
without explanations and examples is presented in
Table 2.
First stage: development
Item 1: Description of the intervention’s underlying the-
oretical basis.
Explanation: The theoretical basis of the interven-
tion includes specific theories, theoretical positions,
Möhler et al. Trials  (2015) 16:204 Page 4 of 9and frameworks guiding the development, design, and
evaluation of the intervention, as well as, if available,
empirical evidence, that is, from studies conducted in
different settings or countries.
Example [20]: “We developed a multifaceted
intervention comprising care plans for both the
practices and the patients (…). By exploring
practitioners’ and patients’ views (…), we determined
the duration and intensity of training within the
practices and the frequency of patient recall. (…)
cognitive theory [Ref] was the main psychological
theory used to develop the training in behavior
change, design the booklet for intervention patients
(Ref ), and inform the development of tailored plans
for patient care. According to this theory, building
patients’ or and facilitating patients in setting goals
and making action plans are central to the optimal
management of chronic disease”.
Item 2: Description of all intervention components,
including the reasons for their selection as well as their
aims/essential functions.
Explanation: Complex interventions are composed
of several interacting components. The description of
the components includes the reasons for selecting a
specific component (for example, experience of or
evidence on the suitability of the component to
achieve the intended change process), and the charac-
teristics of the components (for example, the compo-
nents’ target population, duration, sequence, and
frequency of delivery). Also, the description of theTable 3 Components of the intervention (excerpt) [22]
Intervention Description
Declaration • Declaration confirming the nursing h
to the intervention’s objectives, i.e. the
physical restraints signed by head nurs
directors of each nursing home
Structured 90-minute information
program for all nursing staff
• Definition of physical restraints
• Desired and unwanted effects of phy
• Legal aspects of physical restraint us
• Guideline development and recomm
• Nurses’ subjective attitudes and expe
• Alternative approaches focusing on p
avoidance as most important alternat
External structured 1-day intensive
training workshop for nominated key
nurses from different nursing homes
• Advanced version of 90-min session
• In-depth work with the guideline
• Exchange and discussion between nu
different nursing homes
• Group presentation and discussion o
barriers and facilitators of physical rest
• …aim or essential function of the components rather
than the content in detail is needed, for example, the
content of an education program might differ more
between various countries than the aim or essential
function. A graphical presentation of the components
might be useful [21].
(see Table 3).
Item 3: Illustration of any intended interactions be-
tween different components.
Explanation: In some cases, different components are
designed to support or to enhance the effect of other
components. The description of all intended interactions
between components is highly relevant. This could be
supplemented by a graphical illustration.
Example [23]: “A structured single information session of
approximately 90 minutes will be provided for each
cluster of the intervention group, so that at best all nurses
will be informed. The information programme intends to
sensitise nurses about the matter of physical restraints
and the message of the guidance by addressing their
subjective attitudes and experiences. By means of
interactive training sequences nurses are motivated to
discuss and develop alternative approaches. As supporting
materials they receive a short version of the guidance and
reminders like posters, pens, mugs, and note pads”.
Item 4: Description and consideration of the context’s
characteristics in intervention modelling.
Explanation: Considering the context of the interven-




• Proven strategy in previous studies (Ref )
• Cochrane review (Ref )
sical restraints • Theory of planned behavior (Ref )
e • Acknowledging perceived barriers, current practice
culture, and concerns and emotional responses of nursing
staff by using different educational strategies, e.g. working






• Key nurses to support reduction of physical restraints (Ref)
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can be relevant: the macro level (for example, aspects of
financing services, legal and political aspects, education
of professionals), the meso level (for example, institu-
tional or community-specific conditions) and the micro
level (for example, teams, individuals, or local struc-
tures). The description of all aspects judged as relevant
for modelling the intervention is of interest.
Example [20]: “We recruited general practices from
two different healthcare systems in Ireland. The
Republic of Ireland has a mixed healthcare system
and Northern Ireland is served by the UK National
Health Service (…). Key features of healthcare systems
in Northern Ireland and Republic of Ireland: (…)”.
Second stage: feasibility and piloting
Item 5: Description of the pilot test and its impact on
the definite intervention.
Explanation: A pilot study aims to determine the feasi-
bility, acceptability, and/or practicability of a complex inter-
vention. Information on how the intervention was tested
for procedural, clinical, and methodological uncertainties
identified during the development process is crucial.
Example [24]: “Problems were also identified through
testing the process of plan production and delivery
(…). Two substantial changes were made including the
addition of a carer component and the introduction of
manual checking procedures to ensure that all patient
information provided in the plans is correct and all
related secondary prevention advice is appropriate”.
Third stage: evaluation
Item 6: Description of the control condition (compara-
tor) and reasons for the selection.
Explanation: Control conditions can comprise usual
care (that is, standard care without any additional compo-
nent), optimized usual care (that is, standard care with one
or more additional components delivered by the research
team), or an active control condition (that is, another inter-
vention). The description of the characteristics of the con-
trol condition may cover information on professionals or
services available for the target population, as well as infor-
mation on differences in the control condition across study
centers.
Example [20]: “Usual care (…) in Northern Ireland
involved a system for annual review of blood pressure,
cholesterol concentration, smoking status, and
prescribed drugs, in accordance with the criteria
specified within the NHS general practitioner contract
quality and outcomes framework for the management
of coronary heart disease”.Item 7: Description of the strategy for delivering the
intervention within the study context.
Explanation: A pre-planned strategy for delivering the
intervention is crucial. This strategy aims at maintaining
a standardized delivery of the intervention as far as pos-
sible (for example, in case of different study centers), but
can also include methods to deal with local or personnel
conditions and local tailoring of the intervention.
Example [25]: “The training was standardized by
using the same training materials: the trainers (the
research general practitioner and research nurse in
each center) adhered to a single training protocol, and
training delivery was planned and rehearsed jointly by
all trainers using role play and peer review (Ref )”.
Item 8: Description of all materials or tools used for
the delivery of the intervention.
Explanation: Interventions often comprise materials,
for example, brochures, checklists, or flyers. Materials or
tools can be components of the intervention by them-
selves (for example, patient’s diaries or short versions of
guidelines) or a method to ensure the delivery or increase
awareness towards the intervention (for example, posters
or information sheets). These materials might impact the
intervention effect; therefore information on their aims,
content, format, and accessibility, is highly relevant.
Example [22]:
‘Printed supportive material:
 Provision of the guideline’s 16-page short version for
all nursing staff,
 Provision of the guideline’s 16-page short version for
legal guardians and relatives focusing on legal aspects,
 Provision of a leporello-style flyer for relatives and
other visitors with information about the project’s
main objectives.
‘Other supportive material:
 Provision of posters with the intervention’s logo and
slogan (‘Dare more freedom’),
 Provision of pencils and post-its with the intervention’s
logo for all nurses attending the educational session
 Provision of mugs with the intervention’s logo for key
nurses’.
Item 9: Description of fidelity of the delivery process
compared with the study protocol.
Explanation: Information on the actual delivery of the
intervention and on any deviation from the study proto-
col during the study is of interest. If any deviation oc-
curred, information on necessary adjustments of single
components or the entire intervention is relevant.
Table 4 Table (excerpt)
Process Measures Process Variables
1. Quality of delivery of the
interventional components
1a. The part of each component and
the complete intervention delivered
by instructors;
b. Satisfaction with delivery
2. Barriers and facilitators for
delivery of interventional
components
2. Reasons for diverging from, or
applying (planned) components
3. Adherence to interventional
components
3a. Number of sessions followed;
b. Intervention components (partly)
followed;
c. Compliance to individual
recommendations;
d. Homework adherence
4. Barriers and facilitators for
adherence to interventional
components
4. Motivation for (lack of ) attendance
and compliance




b. Strong and weak aspects of the
interventional components (structure
and content), and the total
intervention”
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centers or even the whole intervention group.
Example [26]: “The training and intervention were
delivered as planned for the general practitioners,
practice nurses, and peer supporters in the protocol.
All intervention and control practices implemented
structured diabetes care as planned. All the practices
and 28 out of the 29 peer supporters were followed up,
though only 23 of the peer supporters were retained in
their role. The main concern regarding the delivery
and receipt of treatment, that is, the intervention, was
the low attendance at the group meetings. Participants
in the intervention group attended a mean of five peer
support meetings, and 18% never attended a meeting
and therefore had no exposure to the intervention.
This was despite repeated phone calls from practice
nurses and a call from the study manager to all
nonattenders after the third round of meetings”.
Item 10: Description of a process evaluation and its
underlying theoretical basis.
Explanation: Process evaluation is a prerequisite in de-
termining the success of the intervention’s delivery. Infor-
mation on the theoretical basis, methods, and results of a
process evaluation is relevant to understand the effects of
the intervention. Process evaluation should be planned a
priori and rely on an established framework, for example,
Linnan and Steckler [27] or Grant [16].
Example [28]: “We preplanned a process evaluation
for our newly developed fall-prevention program (…).
Because of the frailty of our population, we tried to as-
sess as many variables as possible with simple ques-
tionnaires or registration forms. In addition, we
performed short semistructured interviews among par-
ticipants and instructors to gather information about
their experiences and thoughts”.
(see Table 4).
Item 11: Description of internal facilitators and bar-
riers potentially influencing the delivery of the interven-
tion as revealed by the process evaluation.
Explanation: The process evaluation may reveal in-
ternal facilitators or barriers identified within the study
context, for example, resources, staff reluctance, or
unforeseen staff turnover. It is important to describe
facilitators or barriers from different perspectives, for
example, participants, staff, research team.
Example [22]: “The qualitative analysis of 40 in-depth
interviews with nominated key nurses and head nurses
identified important facilitators of and barriers to re-
ducing prevalence of physical restraint use. Potentialfacilitators were supportive attitudes among head
nurses; in-house quality circles with case discussion;
counselling and education of relatives; and explicit
and qualified information for judges, legal guardians,
and physicians. Important barriers were negative expe-
riences of nurses, concerns and uncertainties of rela-
tives and legal guardians, and organizational
problems (for example, staff fluctuation).”
Item 12: Description of external conditions or factors
occurring during the study that might have influenced
the delivery of the intervention or mode of action (that
is, how it works).
Explanation: External conditions or factors may be
unforeseen changes in clinical practice that have been
observed during the delivery of the intervention or dur-
ing the study period. External conditions or factors
might be the introduction of new guidelines, set up of
policies or laws. or organizational changes.
Example [29]: “In March 2004, the Committee on
Safety of Medicines wrote to all doctors in the
United Kingdom to advise against the prescription
of risperidone and olanzapine in patients with
dementia. The effect of this communication, which
might have been expected to result in
discontinuation of neuroleptics in a large number of
participants in both arms of the trial, was only
modest. Differences in the proportion of patients
receiving neuroleptics at each review (…) between
the groups were sustained over the year, and
similarly affected by the ruling of the Committee on
Safety of Medicines.”
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the delivery of the intervention.
Explanation: Information on all expenses is needed,
for example, personnel costs, material, or equipment.
Example [30]: “The average direct cost of the
intervention, including nurse time and psychiatrist
supervision (but not the cost of nurse training or
screening for depression), was £261.65 per patient.
Patients who received the intervention also had slightly
greater costs for healthcare than did those who had
usual care (£175.33 versus £151.44, difference £23.89)
and for antidepressant drugs (£70.11 versus £20.79,
difference £49.32). The total average extra cost of the
intervention was therefore £334.86 (95% confidence
interval £276 to £393) per patient over 6 months (…).”
Discussion
CReDECI 2 is a reporting guideline with 13 items, which
offers guidance for a comprehensive reporting of the devel-
opment, piloting, and evaluation of complex interventions
in healthcare. The reporting guideline has been revised
based on a formal consensus process, following the recom-
mendations of the EQUATOR network [18]. The attendees
of the consensus conference were scientists from several
European countries with methodological and clinical ex-
pertise in the development and evaluation of complex inter-
ventions, partly also with experience as journal editors.
This composition of the consensus group is comparable to
other reporting guidelines [31] and allowed the integration
of a broad range of competencies and experiences. The
number of attendees, 45, of the consensus conference was
in the upper range of other reporting guidelines [31].
Complex interventions are an important topic in
healthcare research and there are several frameworks
available offering methodological guidance [32]. In all
frameworks, the use of qualitative and quantitative study
designs is recommended during the research process of
developing and evaluating complex interventions [4,33].
Available reporting guidelines, which include items rele-
vant for complex interventions, focus on the evaluation
stage (Table 1). In contrast, CReDECI 2 covers all rele-
vant methodological aspects that should be reported
during the research process of the development, piloting,
and evaluation of a complex intervention, but without
focusing on specific study designs. Although a report of
the main characteristics of the intervention and its de-
velopment should be included in the publication of the
evaluation trial, an additional publication on the devel-
opment and piloting of the intervention is often needed
to report all relevant information.
To ensure comprehensive reporting of all study
design-specific criteria, further available reporting guide-
lines should be used [3].Like the original criteria list [7], the CReDECI 2 cri-
teria are organized according to the first three stages of
the MRC framework for the development and evaluation
of complex interventions [4]. However, the guideline was
developed based on relevant methodological literature
on complex interventions, without focusing on a specific
framework. Therefore, CReDECI 2 can be used for all
complex interventions, irrespective of the methodo-
logical framework or model guiding its development and
evaluation. The last stage of the MRC framework [4],
long-term implementation, is not part of CReDECI 2,
which focuses on the development and evolution of the
interventions, whereas the fourth stage targets interven-
tions which have proved to be effective [7].
The reporting quality of complex interventions varied in
different analyses and in different stages. Several studies
showed that reporting of the development and evaluation
of complex interventions is insufficient [34-36]. There is
evidence that the endorsement of CONSORT by health-
care journals has led to an improvement in reporting qual-
ity [37]. Although, evidence is lacking for other reporting
guidelines [38], it seems likely that applying CReDECI 2
will lead to an improved reporting quality in complex in-
terventions. CReDECI is listed in the overview of the
EQUATOR network [3] and used in the Agency for
Healthcare Research and Quality’s research white paper
on systematic reviews of complex interventions [39].
Conclusions
With CReDECI 2, a formally consented revised reporting
guideline becomes available, which guides manuscript
preparation in the development, piloting, and evaluation
of complex interventions. The original guideline showed
its practicability [17] and since the structure of CRe-
DECI 2 remains unchanged, this seems valid for the re-
vised guideline too.
Although CReDECI aims to cover most of the pro-
cesses of developing and evaluating complex interven-
tions, it is relatively concise as, for example, it does not
focus on design-specific methodological details. There-
fore, CReDECI 2 could be used as a specific instrument
for complex interventions alongside design-specific
reporting guidelines, for example, CONSORT for RCTs
[8]. The decision on the choice of additional design-
specific instruments has to be left to the discretion of
study authors or reviewers.Additional files
Additional file 1: Changes from the original CReDECI to the revised
CReDECI 2 criteria list.
Additional file 2: REFLECTION CReDECI Consensus Group, list of
participants.
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